These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8490714)

  • 1. Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine.
    Cador M; Cole BJ; Koob GF; Stinus L; Le Moal M
    Brain Res; 1993 Mar; 606(2):181-6. PubMed ID: 8490714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine induced sensitization in acoustic startle: lack of blockade by adrenalectomy and alpha-helical CRF9-41.
    Chen DY; Liang KC
    Chin J Physiol; 2002 Jun; 45(2):75-87. PubMed ID: 12817721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role.
    Cador M; Ahmed SH; Koob GF; Le Moal M; Stinus L
    Brain Res; 1992 Dec; 597(2):304-9. PubMed ID: 1473001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone.
    Britton KT; Lee G; Dana R; Risch SC; Koob GF
    Life Sci; 1986 Oct; 39(14):1281-6. PubMed ID: 3489874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress.
    Imaki T; Shibasaki T; Hotta M; Demura H
    Brain Res; 1993 Jul; 616(1-2):114-25. PubMed ID: 8358602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential behavioral actions of corticotropin-releasing factor (CRF).
    Veldhuis HD; De Wied D
    Pharmacol Biochem Behav; 1984 Nov; 21(5):707-13. PubMed ID: 6334857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior.
    Cole BJ; Cador M; Stinus L; Rivier C; Rivier J; Vale W; Le Moal M; Koob GF
    Life Sci; 1990; 47(19):1715-20. PubMed ID: 2250584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of aminoprocalcitonin inhibits food intake and stimulates the hypothalamic-pituitary-adrenal axis in rats via the corticotrophin-releasing factor system.
    Tavares E; Maldonado R; Garcia-Martinez A; Miñano FJ
    J Neuroendocrinol; 2012 Jul; 24(7):1040-54. PubMed ID: 22372932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
    Russig H; Pryce CR; Feldon J
    Brain Res; 2006 Apr; 1084(1):185-95. PubMed ID: 16563358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats.
    Eutamene H; Theodorou V; Fioramonti J; Bueno L
    J Physiol; 2003 Dec; 553(Pt 3):959-66. PubMed ID: 14555722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization.
    Cole BJ; Cador M; Stinus L; Rivier J; Vale W; Koob GF; Le Moal M
    Brain Res; 1990 Apr; 512(2):343-6. PubMed ID: 2354366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
    Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
    J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
    Erb S; Brown ZJ
    Behav Brain Res; 2006 Sep; 172(2):360-4. PubMed ID: 16822557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.
    Diamant M; de Wied D
    Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor administered intraventricularly to rhesus monkeys.
    Kalin NH; Shelton SE; Kraemer GW; McKinney WT
    Peptides; 1983; 4(2):217-20. PubMed ID: 6312434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
    Bjijou Y; Stinus L; Le Moal M; Cador M
    J Pharmacol Exp Ther; 1996 May; 277(2):1177-87. PubMed ID: 8627530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis.
    Rock JP; Oldfield EH; Schulte HM; Gold PW; Kornblith PL; Loriaux L; Chrousos GP
    Brain Res; 1984 Dec; 323(2):365-8. PubMed ID: 6335410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.